With dramatic changes in lifestyles over the last 20 years, nonalcoholic fatty liver disease
(NAFLD) has become the most prevalent liver disorder in China but has not received …

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease, with a worldwide
prevalence of 25%. In the United States, NAFLD and its subtype, nonalcoholic …

Aims To conduct a systematic literature review to identify recent epidemiological, biomarker,
genetic and clinical evidence that expands our understanding of nonalcoholic fatty liver …

Nonalcoholic fatty liver disease (NAFLD) has rapidly become the most common form of
chronic liver disease in children and adolescents. Over the past 5 years, developments have …

The pathophysiology of NAFL and NASH is complex and numerous intermediaries are
involved. Each year brings new and exciting developments as pieces of the …

Non‐alcoholic fatty liver disease (NAFLD) affects 25% of the population and can progress to
cirrhosis with limited treatment options. As the liver secretes most of the blood plasma …

This paper aims to update the clinical researches using superparamagnetic iron oxide
(SPIO) nanoparticles as magnetic resonance imaging (MRI) contrast agent published during …

Non-alcoholic fatty liver disease (NAFLD) is a major cause of chronic liver disease,
encompassing a spectrum from non-alcoholic fatty liver to non-alcoholic steatohepatitis …

Nonalcoholic fatty liver disease (NAFLD) is generally considered a silent and potentially
reversible condition. The subtype of NAFLD that can be classified as nonalcoholic …

Nonalcoholic fatty liver disease is a major global health concern with increasing prevalence,
associated with obesity and metabolic syndrome. Recently, quantitative ultrasound-based …